The Winter 2020 edition of the newsletter on SWOG's Lung-MAP precision medicine trial is out. Lung-MAP is NCI's first precision trial, and tests new treatments for non-small cell cancer in partnership with the National Cancer Institute, Foundation for the National Institutes of Health, and Friends of Cancer Research.

The newsletter gives a grateful accounting of progress made during this remarkable year, with over 900 study registrations. It also also includes links to the latest Lung-MAP manuscript, published in The Lancet Oncology, and a list of new study leaders. Read the newsletter here.

Other Recent Stories

SWOG Front Line banner
Nov 7, 2025
We have many inspiring stories of accrual heroes
SWOG Front Line banner
Oct 31, 2025
After two 3-day meetings, what do the surveys say?
SWOG Front Line banner
Oct 24, 2025
Yet more evidence of the essential role of federal support in cancer research